Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy.
Cheng-Hsiang LoJen-Fu YangMing-Yueh LiuYee-Min JenChun-Shu LinHsing-Lung ChaoWen-Yen HuangPublished in: PloS one (2017)
SABR may be useful for patients with advanced HCC, and patient selection could be based on the CTP classification, main portal vein tumor thrombosis, and extrahepatic spread.